Background: Anemia may be present in patients with chronic obstructive pulmonary disease (COPD) and further impair their functional capacity. Objectives: This study investigated the prevalence of anemia of chronic disease (ACD) in COPD patients and its impact on dyspnea and exercise capacity, utilizing cardiopulmonary exercise testing (CPET). Methods: ACD prevalence was assessed in 283 consecutive patients with stable COPD (263 males, 60 females; age 60.31 ± 5.34 years; percent forced expiratory volume in 1 s 46.94 ± 6.12). ACD diagnosis was based on a combination of clinical and laboratory parameters [hemoglobin (Hb) <13 g/dl for males, <12 g/dl for females; ferritin >30 ng/ml; total iron-binding capacity <250 µg/dl, and transferrin saturation rate between 15 and 50%]. Twenty-seven patients who were identified with ACD (cases) and 27 matched nonanemic patients (controls) completed maximal CPET, and data were compared between the groups. Results: ACD was diagnosed in 29 patients, which represents a prevalence of 10.24%; the severity of anemia was generally mild (mean Hb: 12.19 ± 0.66 g/dl). Patients with ACD had a higher Medical Research Council dyspnea score compared to controls (2.78 ± 0.44 vs. 2.07 ± 0.55; p <0.001) and lower peak O2 uptake (VO2) (59.54 ± 17.17 vs. 71.26 ± 11.85% predicted; p <0.05), peak work rate (54.94 ± 21.42 vs. 68.72 ± 20.81% predicted; p <0.05) and peak VO2/heart rate (69.07 ± 17.26 vs. 82.04 ± 18.22% predicted; p <0.05). There was also a trend for a lower anaerobic threshold (48.48 ± 15.16 vs. 55.42 ± 9.99% predicted; p = 0.062). No exercise parameter indicative of respiratory limitation differed between the groups. Conclusions: ACD occurs in approximately 10% of stable COPD patients and has a negative impact on dyspnea and circulatory efficiency during exercise.

1.
Weiss G: Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 2002;16:87–96.
[PubMed]
2.
Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005;352:1011–1023.
[PubMed]
3.
Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639–1647.
[PubMed]
4.
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271–1276.
[PubMed]
5.
Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165–1185.
[PubMed]
6.
van Helvoort HA, Heijdra YF, Dekhuijzen PN: Systemic immunological response to exercise in patients with chronic obstructive pulmonary disease: what does it mean? Respiration 2006;73:255–264.
[PubMed]
7.
Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP: Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856–1861.
[PubMed]
8.
Krishnan G, Grant BJ, Muti PC, Mishra A, Ochs-Balcom HM, Freudenheim JL, Trevisan M, Schünemann HJ: Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006;6:23.
[PubMed]
9.
Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF: Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006;4:17.
[PubMed]
10.
John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD: Anemia and inflammation in COPD. Chest 2005;127:825–829.
[PubMed]
11.
Chambellan A, Chailleux E, Similowski T: Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005;128:1201–1208.
[PubMed]
12.
Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B: Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007;29:923–929.
[PubMed]
13.
Ferrazza AM, Martolini D, Valli G, Palange P: Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009;77:3–17.
[PubMed]
14.
Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932–946.
[PubMed]
15.
Tettamanti M, Lucca U, Gandini F, Recchia A, Mosconi P, Apolone G, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Savoia L, Fasolo G, Ponchio L, Della Porta MG, Riva E: Prevalence, incidence and types of mild anemia in the elderly: the ‘Health and Anemia’ population-based study. Haematologica 2010;95:1849–1856.
16.
Ahluwalia N, Lammi-Keefe CJ, Bendel RB, Morse EE, Beard JL, Haley NR: Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis approach for differentiation. Am J Clin Nutr 1995;61:590–596.
17.
Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 1997;277:973–976.
[PubMed]
18.
Carmel R, Green R, Rosenblatt DS, Watkins D: Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003:62–81.
19.
Rossert J, Froissart M: Role of anemia in progression of chronic kidney disease. Semin Nephrol 2006;26:283–289.
[PubMed]
20.
ATS/ACCP: Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211–277.
[PubMed]
21.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005;26:319–338.
[PubMed]
22.
Ross RM: ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:1451.
23.
Wasserman K, Hansen LE, Sue DY, Stringer WW, Whipp BJ: Principles of Exercise Testing and Interpretation, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2005.
24.
Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020–2027.
[PubMed]
25.
Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B: Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725–734.
[PubMed]
26.
Gold PM: The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care 2009;54:1040–1049.
[PubMed]
27.
Groopman JE, Itri LM: Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616–1634.
[PubMed]
28.
Wilson A, Yu HT, Goodnough LT, Nissenson AR: Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 2004;116(suppl 7A):50S–57S.
[PubMed]
29.
Eknoyan G: The importance of early treatment of the anaemia of chronic kidney disease. Nephrol Dial Transplant 2001;16(suppl 5):45–49.
30.
Odden MC, Whooley MA, Shlipak MG: Association of chronic kidney disease and anemia with physical capacity: the heart and soul study. J Am Soc Nephrol 2004;15:2908–2915.
[PubMed]
31.
Agostoni P, Salvioni E, Debenedetti C, Vignati C, Cattadori G, Contini M, Magrì D, Palermo P, Gondoni E, Brusoni D, Fiorentini C, Apostolo A: Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients. Am J Hematol 2010;85:414–417.
32.
Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003;107:294–299.
[PubMed]
33.
Evans WJ: Physical function in men and women with cancer. Effects of anemia and conditioning. Oncology (Williston Park) 2002;16(9 suppl 10):109–115.
34.
Dudgeon DJ, Lertzman M, Askew GR: Physiological changes and clinical correlations of dyspnea in cancer outpatients. J Pain Symptom Manage 2001;21:373–379.
35.
Culver BH: Physiology; in Albert RK, Spiro SG, Jett JR (eds): Comprehensive Respiratory Medicine, ed 1. St Louis, Mosby Inc, 1999, pp 89–150.
36.
O’Regan RG, Majcherczyk S: Role of peripheral chemoreceptors and central chemosensitivity in the regulation of respiration and circulation. J Exp Biol 1982;100:23–40.
37.
Palazzuoli A, Quatrini I, Calabrò A, Antonelli G, Caputo M, Campagna MS, Franci B, Nuti R: Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. Clin Exp Med 2011;11:43–48.
38.
Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna MS, Nuti R: Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J 2006;152:1096.e9–1096.e15.
[PubMed]
39.
Silverberg DS, Wexler D, Blum M, Sheps D, Schwartz D, Yachnin T, Baruch R, Tchebiner J, Zubkov A, Shaked M, Steinbruch S, Keren G, Iaina A: Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases. Perit Dial Int 2001;21(suppl 3):S236–S240.
40.
Bedani PL, Verzola A, Bergami M, Stabellini G, Gilli P: Erythropoietin and cardiocirculatory condition in aged patients with chronic renal failure. Nephron 2001;89:350–353.
41.
Schonhofer B, Wenzel M, Geibel M, Kohler D: Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998;26:1824–1828.
[PubMed]
42.
Schonhofer B, Bohrer H, Kohler D: Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998;53:181–184.
43.
Sichletidis L, Tsiotsios I, Gavriilidis A Chloros D, Kottakis I, Daskalopoulou E, Konstantinidis T: Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece. Respiration 2005;72:270–277.
[PubMed]
44.
Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N: Prevalence of COPD in Greece. Chest 2004;125:892–900.
[PubMed]
45.
Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC: Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004;104:2263–2268.
[PubMed]
46.
Chaves PH, Ashar B, Guralnik JM, Fried LP: Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 2002;50:1257–1264.
[PubMed]
47.
Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, Fried LP: Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women’s Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2005;60:729–735.
[PubMed]
48.
Minas M, Hatzoglou C, Karetsi E, Tanou K, Tsaroucha R, Gogou E, Gourgoulianis KI, Kostikas K: COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J 2010;19:363–370.
You do not currently have access to this content.